
From Underdog to $12B Exit: How Biohaven Pharma Turned Coaching Into a Competitive Weapon
When Biohaven Pharma launched into the migraine market, the odds were not in their favor. They faced entrenched competitors with deeper pockets, bigger salesforces, and broader reach. And yet, they...
Read More →